OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc under contract SPE2DP26F6322, with an award date of June 3, 2026, for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068. This award is issued as a delivery order under the parent contract SPE2DX25D9900, and the total contract value is detailed in the official award documentation. The solicitation was posted on DIBBS on July 21, 2026, and the contract is classified as a federal award with no specific set-aside designation. The performance location and point of contact information are not specified in the available data, but the contracting agency is the Department of Defense through the Defense Logistics Agency, and the awardee is registered with CAGE code 1UNB0. The delivery of the pharmaceutical product is intended to support federal medical requirements, with the contract link accessible through the DIBBS system.
General Info
Agency
Contract Value
$50.8NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
